Previous 10 | Next 10 |
Shares of Zynex (NASDAQ: ZYXI) were crashing 17.8% lower as of 11:21 a.m. EST on Friday. The steep drop came after the medical technology company announced its fourth-quarter results following the market close on Thursday. It wasn't that Zynex's Q4 results were bad. The company ...
Gainers: Xtant Medical (XTNT) +54%, Sensus Healthcare (SRTS) +34%, Rubius Therapeutics (RUBY) +23%, Select Medical (SEM) +18%, Dynavax Technologies (DVAX) +18%.Losers: Tricida (TCDA) -32%, Recro Pharma (REPH) -27%, Zynex (ZYXI) -17%,...
Image source: The Motley Fool. Zynex, Inc (NASDAQ: ZYXI) Q4 2020 Earnings Call Feb 25, 2021 , 4:15 p.m. ET Operator Continue reading For further details see: Zynex, Inc (ZYXI) Q4 2020 Earnings Call Transcript
Fate Therapeutics (FATE) initiated with a Buy at BofA Securities. PT set to $115, implies a 33% increase from last price.Wedbush analyst David Nierengarten downgraded FATE to Neutral from Outperform as it sees “higher downside risk”and less reward as clinical programs advance an...
Zynex, Inc. (ZYXI) Q4 2020 Results Earnings Conference Call February 25, 2021, 04:15 PM ET Company Participants Thomas Sandgaard - Founder, Chairman, and Chief Executive Officer Dan Moorhead - Chief Financial Officer Conference Call Participants Yi Chen - H.C. Wainwright & Co. Jeffrey Coh...
Zynex Announces 2020 Fourth Quarter and Full Year Earnings PR Newswire ENGLEWOOD, Colo. , Feb. 25, 2021 /PRNewswire/ -- 2020 Full Year Revenue increased 76% year over year to $80.1 million Orders increased 96% Net...
Zynex Schedules 2020 Fourth Quarter and Full-Year Earnings Call PR Newswire ENGLEWOOD, Colo., Feb. 18, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical ...
Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical PR Newswire ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive m...
Medical technology company Zynex (ZYXI) has filed for a provisional patent for a noninvasive sepsis monitor for treating the life-threatening medical condition characterised by the body-wide inflammatory response or reaction that presents in response to infection.The signs and sympt...
Zynex Announces Filing of Patent for Sepsis Monitor PR Newswire ENGLEWOOD, Colo. , Jan. 14, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Zynex Inc CEO Thomas Sandgaard joined Steve Darling from Proactive to announce the company's financial and operational results for the second quarter ending June 30, 2024, in an interview with Proactive. The company achieved a remarkable 20% year-over-year increase in orde...
2024-07-26 16:37:00 ET Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical equipment company reported earnings last night that, on a headl...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...